{"id":"W2558410094","doi":"10.1182/blood.v110.11.3419.3419","title":"Durable Complete Responses Following Therapy with Epratuzumab Plus Rituximab: Final Efficacy Results of a Multicenter Study in Recurrent Indolent Non-Hodgkin’s Lymphoma (NHL).","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Rituximab; Medicine; Follicular lymphoma; Internal medicine; Regimen; Lymphoma; Gastroenterology; Refractory (planetary science); Oncology; Chemotherapy regimen; Chemotherapy; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004792303,0.001364641,0.002164602,0.0003846152,0.000494266,0.00087989,0.0009021849,0.001058918,0.001332934],"category_scores_gemma":[0.001590751,0.0005288704,0.001319709,0.0004207753,0.0007905957,0.0007570826,0.0003865005,0.002020713,0.0007179138],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006604906,"about_ca_system_score_gemma":0.000538222,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005219076,"about_ca_topic_score_gemma":0.0005533224,"domain_scores_codex":[0.9986901,0.000732999,0.00007875478,0.0001951409,0.0001166963,0.0001863748],"domain_scores_gemma":[0.9984474,0.0002333808,0.0003651704,0.0003056,0.00009270489,0.0005558348],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5229695,0.08005169,0.07582239,0.000538509,0.005122937,0.001625244,0.001248582,0.002270668,0.1206021,0.0001888915,0.003733789,0.1858257],"study_design_scores_gemma":[0.1894181,0.6061912,0.1827033,0.00004491792,0.003452616,0.002261275,0.0001821565,0.001825891,0.01053641,0.0001315364,0.003172114,0.00008043572],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9979139,0.0009992779,0.0002978016,0.00006832179,0.00002095834,0.0001604703,0.0001947319,0.0000281085,0.0003164179],"genre_scores_gemma":[0.9972652,0.0004320877,0.0005070501,0.0001850276,0.0001116701,0.0002022618,0.0008935339,0.00001565551,0.0003875832],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004792303,"threshold_uncertainty_score":0.02534443,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04199674857594948,"score_gpt":0.3145786416105459,"score_spread":0.2725818930345965,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}